Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 165 filings · Latest: Oct 15, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 30, 2026
Sale
$572.639,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 30, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
MARTINE ROTHBLATT—May 1, 2026
Proposed Sale
$571.35190,000$108.6M—
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 29, 2026
Sale
$571.229,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 29, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 28, 2026
Sale
$568.049,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 28, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 27, 2026
Sale
$568.819,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 27, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 24, 2026
Sale
$564.819,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 24, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 23, 2026
Sale
$572.359,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 23, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 22, 2026
Sale
$576.569,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 22, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 21, 2026
Sale
$570.429,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 21, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 20, 2026
Sale
$577.839,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 20, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 17, 2026
Sale
$586.669,500$5.6M40,513